Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Evaluating Associations Between Non-neuronal Autoimmune Disorders and Psychosis.

Brown R, Zandi MS.

Biol Psychiatry. 2019 Jan 1;85(1):8-9. doi: 10.1016/j.biopsych.2018.10.010. No abstract available.

PMID:
30527211
2.

Autoimmune encephalitis.

Midgley L, Kelleher E, Zandi MS.

Br J Hosp Med (Lond). 2018 Sep 2;79(9):C134-C137. doi: 10.12968/hmed.2018.79.9.C134. No abstract available.

PMID:
30188216
3.

Study of immunotherapy in antibody positive psychosis: feasibility and acceptability (SINAPPS1).

Lennox BR, Tomei G, Vincent SA, Yeeles K, Pollard R, Palmer-Cooper E, Jones P, Zandi MS, Coles A.

J Neurol Neurosurg Psychiatry. 2018 Jun 11. pii: jnnp-2018-318124. doi: 10.1136/jnnp-2018-318124. [Epub ahead of print] No abstract available.

PMID:
29891740
4.

The witchcraft of encephalitis in Salem.

Tam J, Zandi MS.

J Neurol. 2017 Jul;264(7):1529-1531. doi: 10.1007/s00415-017-8546-4. Epub 2017 Jun 19. No abstract available.

PMID:
28631128
5.

Bone health in patients with multiple sclerosis relapses.

Murphy O, Zandi MS, Lindenberg N, Murphy E, Chataway J.

Mult Scler Relat Disord. 2016 Mar;6:75-80. doi: 10.1016/j.msard.2016.02.003. Epub 2016 Feb 8.

PMID:
27063628
6.

The Importance of Keeping in Mind the Diagnosis of N-Methyl-D-Aspartate Receptor Encephalitis.

Zandi MS, Lennox BR, Vincent A.

Biol Psychiatry. 2016 Aug 15;80(4):e15. doi: 10.1016/j.biopsych.2015.08.038. Epub 2015 Nov 14. No abstract available.

PMID:
26742924
7.

N-Methyl-D-Aspartate Receptor Autoantibodies in Psychiatric Illness.

Zandi MS, Lennox B, Vincent A.

Biol Psychiatry. 2016 May 1;79(9):e61. doi: 10.1016/j.biopsych.2015.03.034. Epub 2015 Jun 9. No abstract available.

PMID:
26185011
8.

Immunotherapy for patients with acute psychosis and serum N-Methyl D-Aspartate receptor (NMDAR) antibodies: a description of a treated case series.

Zandi MS, Deakin JB, Morris K, Buckley C, Jacobson L, Scoriels L, Cox AL, Coles AJ, Jones PB, Vincent A, Lennox BR.

Schizophr Res. 2014 Dec;160(1-3):193-5. doi: 10.1016/j.schres.2014.11.001. Epub 2014 Nov 15. No abstract available.

PMID:
25468187
9.

Clinical relevance of serum antibodies to extracellular N-methyl-D-aspartate receptor epitopes.

Zandi MS, Paterson RW, Ellul MA, Jacobson L, Al-Diwani A, Jones JL, Cox AL, Lennox B, Stamelou M, Bhatia KP, Schott JM, Coles AJ, Kullmann DM, Vincent A.

J Neurol Neurosurg Psychiatry. 2015 Jul;86(7):708-13. doi: 10.1136/jnnp-2014-308736. Epub 2014 Sep 22.

10.

Recent advances in the neuroimmunology of cell-surface CNS autoantibody syndromes, Alzheimer's disease, traumatic brain injury and schizophrenia.

Needham E, Zandi MS.

J Neurol. 2014 Oct;261(10):2037-42. doi: 10.1007/s00415-014-7473-x. Epub 2014 Sep 3. Review.

PMID:
25182699
11.

Long-term remission with rituximab in refractory leucine-rich glioma inactivated 1 antibody encephalitis.

Brown JW, Martin PJ, Thorpe JW, Michell AW, Coles AJ, Cox AL, Vincent A, Zandi MS.

J Neuroimmunol. 2014 Jun 15;271(1-2):66-8. doi: 10.1016/j.jneuroim.2014.03.012. Epub 2014 Mar 21.

PMID:
24703099
12.

Defining and treating leucine-rich glioma inactivated 1 antibody associated autoimmunity.

Zandi MS.

Brain. 2013 Oct;136(Pt 10):2933-5. doi: 10.1093/brain/awt256. No abstract available.

PMID:
24072484
13.

Antibodies to the N-methyl-D-aspartate receptor and other synaptic proteins in psychosis.

Deakin J, Lennox BR, Zandi MS.

Biol Psychiatry. 2014 Feb 15;75(4):284-91. doi: 10.1016/j.biopsych.2013.07.018. Epub 2013 Aug 26. Review.

PMID:
23988024
14.

Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: experience from a tertiary referral centre.

Paterson RW, Zandi MS, Armstrong R, Vincent A, Schott JM.

J Neurol Neurosurg Psychiatry. 2014 Jun;85(6):625-30. doi: 10.1136/jnnp-2013-305218. Epub 2013 Jun 11.

15.

Disease-relevant autoantibodies in first episode schizophrenia.

Zandi MS, Irani SR, Lang B, Waters P, Jones PB, McKenna P, Coles AJ, Vincent A, Lennox BR.

J Neurol. 2011 Apr;258(4):686-8. doi: 10.1007/s00415-010-5788-9. Epub 2010 Oct 26. No abstract available.

16.

A novel strategy to reduce the immunogenicity of biological therapies.

Somerfield J, Hill-Cawthorne GA, Lin A, Zandi MS, McCarthy C, Jones JL, Willcox M, Shaw D, Thompson SA, Compston AS, Hale G, Waldmann H, Coles AJ.

J Immunol. 2010 Jul 1;185(1):763-8. doi: 10.4049/jimmunol.1000422. Epub 2010 Jun 2.

17.

N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes.

Irani SR, Bera K, Waters P, Zuliani L, Maxwell S, Zandi MS, Friese MA, Galea I, Kullmann DM, Beeson D, Lang B, Bien CG, Vincent A.

Brain. 2010 Jun;133(Pt 6):1655-67. doi: 10.1093/brain/awq113.

18.

Limbic encephalitis associated with antibodies to the NMDA receptor in Hodgkin lymphoma.

Zandi MS, Irani SR, Follows G, Moody AM, Molyneux P, Vincent A.

Neurology. 2009 Dec 8;73(23):2039-40. doi: 10.1212/WNL.0b013e3181c55e9b. No abstract available.

PMID:
19996080
19.

Notes on the kidney and its diseases for the neurologist.

Zandi MS, Coles AJ.

J Neurol Neurosurg Psychiatry. 2007 May;78(5):444-9. Review.

Supplemental Content

Loading ...
Support Center